e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
COPD: chronic disease and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers in COPD- The role of resistin and leptin
Vlasios Vitsas (Athens, Greece), Vlasios Vitsas, Kardara Matina, Vasileiou Aliki, Koutsoukou Antonia, Michalopoulou Pinelopi, Orfanos Stylianos, Tsoukalas Georgios, Kotanidou Anastasia
Source:
International Congress 2015 – COPD: chronic disease and comorbidities
Session:
COPD: chronic disease and comorbidities
Session type:
Thematic Poster Session
Number:
691
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vlasios Vitsas (Athens, Greece), Vlasios Vitsas, Kardara Matina, Vasileiou Aliki, Koutsoukou Antonia, Michalopoulou Pinelopi, Orfanos Stylianos, Tsoukalas Georgios, Kotanidou Anastasia. Biomarkers in COPD- The role of resistin and leptin. Eur Respir J 2015; 46: Suppl. 59, 691
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Serum sirtuin-1 is reduced in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Serum periostin and exercise-induced asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Serum adiponectin in hospitalised patients with COPD: Relationship with peripheral muscle function, physical performance and readmissions
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Variants of apelin gene and COPD
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016
Monitoring catalase activity in COPD exacerbations
Source: International Congress 2016 – Airway biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept